Where Can Science and Policy Meet?

Twenty years ago, the politicians began to realize that science policy was too important to be left to the scientists. Now, the scientists have learned that it is also too important to be left to the politicians. Both sides need to talk to each other, but they face each other across a gap of comprehension. As J.L. Heilbron pointed out recently (The Scientist, March 9, 1987, p. 11), there is a real job here for the historians of science. They have had to master the languages of both science and p

Written byJohn Ziman
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

As J.L. Heilbron pointed out recently (The Scientist, March 9, 1987, p. 11), there is a real job here for the historians of science. They have had to master the languages of both science and politics, and to interpret between them. What they are now learning about the development of contemporary science contains important lessons for its future direction.

Professor Heilbron made it clear that he was talking here of the history of science in the broadest sense, including the sociology, philosophy, psychology, politics, economics and so forth of all the sciences and their associated technologies. The various metascientific disciplines (if that is not too pretentious a word) are converging and coalescing. From this general area of science studies are coming much more coherent images of science as a social institution—images that are much more relevant to policy than the traditional chronicles of discovery.

Policy-makers need access to the images ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies